Purines and Myocardial Protection: Developments in Cardiovascular Medicine, cartea 181
Editat de Anwar-Saad A. Abd-Elfattah, Andrew S. Wechsleren Limba Engleză Hardback – 31 ian 1996
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 2037.01 lei 6-8 săpt. | |
| Springer Us – 27 sep 2011 | 2037.01 lei 6-8 săpt. | |
| Hardback (1) | 2044.07 lei 6-8 săpt. | |
| Springer Us – 31 ian 1996 | 2044.07 lei 6-8 săpt. |
Din seria Developments in Cardiovascular Medicine
- 5%
Preț: 1044.79 lei - 5%
Preț: 380.99 lei - 5%
Preț: 375.50 lei - 5%
Preț: 1047.77 lei - 5%
Preț: 1048.21 lei - 5%
Preț: 1047.77 lei - 5%
Preț: 643.30 lei - 5%
Preț: 630.82 lei - 5%
Preț: 628.80 lei - 5%
Preț: 637.41 lei - 5%
Preț: 636.74 lei - 5%
Preț: 641.94 lei - 5%
Preț: 405.96 lei - 5%
Preț: 383.16 lei - 5%
Preț: 1363.81 lei - 5%
Preț: 362.13 lei - 5%
Preț: 1055.64 lei - 5%
Preț: 1382.39 lei - 5%
Preț: 362.47 lei - 5%
Preț: 354.38 lei - 5%
Preț: 365.81 lei - 5%
Preț: 2034.92 lei - 5%
Preț: 353.34 lei - 5%
Preț: 352.64 lei - 5%
Preț: 357.02 lei - 5%
Preț: 356.87 lei - 5%
Preț: 752.94 lei - 5%
Preț: 685.66 lei - 5%
Preț: 1055.64 lei - 5%
Preț: 361.23 lei - 5%
Preț: 359.30 lei - 5%
Preț: 695.99 lei - 5%
Preț: 1061.25 lei - 5%
Preț: 2034.57 lei - 5%
Preț: 688.44 lei - 5%
Preț: 357.91 lei - 5%
Preț: 694.44 lei - 5%
Preț: 634.66 lei - 5%
Preț: 361.08 lei - 5%
Preț: 1367.84 lei - 5%
Preț: 687.74 lei - 5%
Preț: 760.14 lei
Preț: 2044.07 lei
Preț vechi: 2151.65 lei
-5% Nou
Puncte Express: 3066
Preț estimativ în valută:
361.65€ • 421.33$ • 315.81£
361.65€ • 421.33$ • 315.81£
Carte tipărită la comandă
Livrare economică 17-31 ianuarie 26
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780792338314
ISBN-10: 0792338316
Pagini: 564
Ilustrații: XXIV, 564 p.
Dimensiuni: 155 x 235 x 32 mm
Greutate: 1 kg
Ediția:1996
Editura: Springer Us
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:New York, NY, United States
ISBN-10: 0792338316
Pagini: 564
Ilustrații: XXIV, 564 p.
Dimensiuni: 155 x 235 x 32 mm
Greutate: 1 kg
Ediția:1996
Editura: Springer Us
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
I: Purine Metabolism in the Heart.- 1. Physiologic and Pathophysiologic Significance of Purine Metabolism in the Heart.- 2. Purine Metabolism in the Ischemic Canine and Human Immature Myocardium Deficient of 5?-Nucleotidase.- 3. Cardiac adenosine Metabolism: Physiological Implications.- 4. Purines Metabolism in Human Cardiomyocytes and Endothelium-Implications for Protection of the Heart during Cardiac Surgery.- 5. Assessment of Interstitial Fluid Adenosine: Implications for Exogenous or Endogenous and Endogenous Adenosine-Mediated Cardioprotection.- 6. Adenosine and Coronary Vascular Pharmacology.- 7. Alternations in Energy Substrate Metabolism during Oxidative Stress.- II: Myocardial Protection with Purines.- 8. Purines and Myocardial Protection: An Overview.- A. Myocardial Protection with Endogenous Purines.- 9. Nucleoside Transport Protein: Properties and Regulation.- 10. Role of Nucleoside Transport in Myocardial Injury and Protection: Separation Between Ischemic and Reperfusion Injury using a Selective Nucleoside Transport Blocker, p-Nitrobenzylthoinosine NBMPR.- 11. Myocardial Protection using Nucleoside Transport Inhibitors.- 12. Selective Blockade of Nucleoside Transport by NBMPR Attenuates Reperfusion-Mediated Ventricular Arrhythmias.- 13. Nucleoside Transport in the Human Myocardium.- 14. Selective Nucleoside Transport Blocker NBMPR Attenuates Myocardial Stunning in a Rabbit Model Deficient of Xanthine Oxidase.- 15. Amplification of Endogenous adenosine by “Adenosine Regulating Agents” as a Therapeutic Approach to the Treatment of Cardiac Ischemic Syndromes.- B. Myocardial Protection with Exongenous Purines.- 16. Organ Protection with ATP-Magnesium Chloride.- 17. Adenosine and Adenosine Receptor Protection of the Ischemic Heart.- 18. Effect of Adenosineon Myocardial stunning.- 19. Cardioprotection from Ischemic-Reperfusion Injury by Adenosine.- 20. Cardioprotection with Adenosine, inosine and Hypoxanthine.- 21. Adenosine and Adrenergic Mediated Effects in the Heart.- 22. Effects of Adenosine on Ventricular Tachycardia.- 23. Purines and Ventricular Arrhythmias.- 24. Adenosine and the Polymorphonuclear Leukocyte Function Mechanisms and Production.- 25. Purines and Regulation of Platelet Activation.- III: Purines and Myocardial Preconditioning.- 26. Myocardial Preconditioning: From a Model to a Phenomenon.- 27. ATP Metabolism and Ischemic Preconditioning.- 28. Do Adenosine A3 Receptors Cause Preconditioning?.- 29. KATP Channels and Adenosine Receptors and Ischemic Preconditioning.- 30. Role of Activation of Ecto-5?-Nucleotidase for Cardioprotection in Ischemic and Reperfusion Injury: Role of Purine and Adenosine Metabolism.- 31. Ischemic Preconditions in a Model of Isolated Cardiomyocytes.- 32. Integration of Adenosine and Noradrenergic Pathways in Cardiac Preconditioning.- 33. Myocardial Stunning and Preconditioning during Non-cardioplegic Warm Intermittent Aortic Crossclamping.- IV: Purines and Intracellular Calcium.- 34. Energy and Cation Control in the Reoxygenated Myocardial Cell.- 35. Cystolic Calcium Transport during Myocardial Protection.- 36. Future Therapueitc Use of Purines in Myocardial Protection.